Beyond Statins: Newer Cholesterol Treatments and When They Might Be Right for You

Beyond Statins: Newer Cholesterol Treatments and When They Might Be Right for You

If you've been managing high cholesterol for a while, you've probably heard the word "statin" more times than you can count. Medications like atorvastatin and rosuvastatin remain excellent first-line tools — but they aren't the whole story anymore. For some patients, statins alone aren't enough. For others, muscle aches or other side effects make them difficult to tolerate. The good news? The options available to you in 2025 are broader and more effective than ever before.

When Statins Aren't Enough

Some patients do everything right — take their medication, watch their diet, exercise regularly — and still can't get their LDL (bad cholesterol) to a safe level. This is especially common in people with:

• Familial hypercholesterolemia (FH): A genetic condition that causes very high LDL from birth
• Established cardiovascular disease: Heart attack or stroke survivors often need LDL driven much lower than standard targets
• Statin intolerance: Muscle pain or weakness that makes standard doses hard to sustain

If any of these sound familiar, it may be time to talk to your provider about additional or alternative options.

Newer Medications Worth Knowing About

Ezetimibe (Zetia) This affordable, well-tolerated pill works differently from statins — it reduces how much cholesterol your intestine absorbs. It's often added on top of a statin and can meaningfully lower LDL with minimal side effects.

PCSK9 Inhibitors (Repatha, Praluent) These injectable medications, given every two to four weeks, can slash LDL by 50–60% on top of statin therapy. They work by blocking a protein that limits your liver's ability to clear LDL from the blood. Clinical trials have shown they reduce heart attack and stroke risk. They're typically reserved for high-risk patients due to cost, though insurance coverage has improved significantly.

Bempedoic Acid (Nexletol) A newer oral option approved for statin-intolerant patients. It lowers LDL by acting earlier in the cholesterol production pathway and causes far less muscle-related side effects.

Inclisiran (Leqvio) A newer injectable given just twice a year after an initial dosing period. It uses RNA-based technology to reduce cholesterol production in the liver — a major convenience advantage for patients who struggle with adherence.

What This Means for You

Cholesterol management is no longer one-size-fits-all. Your ideal treatment depends on your LDL level, cardiovascular risk, medical history, tolerance, and personal preferences.

At AmpleHealth, Dr. Dheeraj Kamra and our care team take the time to review your full lipid picture and work with you to build a personalized plan — whether that means optimizing your current statin, adding a second agent, or exploring something entirely new.

Ready to take a closer look at your cholesterol strategy? Schedule an appointment at our Carmichael or Sacramento office and let's make sure your treatment is working as hard as it can for your heart health.